| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/17/2013 | US20130019331 Soybean variety a1024188 |
| 01/17/2013 | US20130019330 Soybean variety a1024175 |
| 01/17/2013 | US20130019329 Soybean variety a1023512 |
| 01/17/2013 | US20130019328 Pepper hybrid ps11423123 |
| 01/17/2013 | US20130019325 Light-Sensitive Ion-Passing Molecules |
| 01/17/2013 | US20130018175 Single variable domain antibodies against ox40l, constructs and therapeutic use |
| 01/17/2013 | US20130018174 Polypeptide modification method for purifying polypeptide multimers |
| 01/17/2013 | US20130018103 Bifunctional histone deacetylase inhibitors |
| 01/17/2013 | US20130018086 Sirnas targeting exon 10 of pyruvate kinase m2 |
| 01/17/2013 | US20130018085 iRNA Agents Targeting VEGF |
| 01/17/2013 | US20130018070 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/17/2013 | US20130018036 Substituted indazole derivatives active as kinase inhibitors |
| 01/17/2013 | US20130018022 Pharmaceutical composition including a testis extract as an active ingredient for treating and preventing anemia |
| 01/17/2013 | US20130017998 Novel modified galectin 9 proteins and use thereof |
| 01/17/2013 | US20130017996 Muteins of tear lipocalin and methods for obtaining the same |
| 01/17/2013 | US20130017991 Hcv protease inhibitors and uses thereof |
| 01/17/2013 | US20130017607 Nanotube carrier substrate for primary tissue culture |
| 01/17/2013 | US20130017606 Method of separating pancreatic islet |
| 01/17/2013 | US20130017605 Orally bioavailable stilbenoids- compositions and therapeutic applications thereof |
| 01/17/2013 | US20130017604 Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| 01/17/2013 | US20130017603 Glutamate derivatives or salts thereof |
| 01/17/2013 | US20130017602 Modulation of oocyte meiotic progression and oocyte activation |
| 01/17/2013 | US20130017601 Modulation of plasma membrane human leukocyte elastase |
| 01/17/2013 | US20130017600 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 01/17/2013 | US20130017599 Method of diminishing the symptoms of neurodegenerative disease |
| 01/17/2013 | US20130017598 Prevention of disulfide bond reduction during recombinant production of polypeptides |
| 01/17/2013 | US20130017597 Use of biological photoreceptors as directly light-activated ion channels |
| 01/17/2013 | US20130017591 Method for the Preparation of Recombinant Human Thrombin and Fibrinogen |
| 01/17/2013 | US20130017583 Methods for producing polyhydroxyalkanoate copolymer with high medium chain length monomer content |
| 01/17/2013 | US20130017582 Enhanced production of taxol and taxanes by cell cultures of taxus species |
| 01/17/2013 | US20130017577 Methods for enhanced protein production |
| 01/17/2013 | US20130017575 Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity |
| 01/17/2013 | US20130017574 Methods and compositions for enhanced expression and secretion of proteins |
| 01/17/2013 | US20130017570 Method for monitoring state of differentiation in stem cell |
| 01/17/2013 | US20130017547 Organ-specific feline endothelial cells and uses thereof |
| 01/17/2013 | US20130017283 Compositions and methods for modulating metabolic pathways |
| 01/17/2013 | US20130017253 Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions |
| 01/17/2013 | US20130017226 TNF-A and TWEAK Dual Antagonist for the Prophylaxis and Treatment of Autoimmune Diseases |
| 01/17/2013 | US20130017223 Methods and compositions for delivery of nucleic acids |
| 01/17/2013 | US20130017222 Human prostate cell lines in cancer treatment |
| 01/17/2013 | US20130017209 A-beta binding polypeptides |
| 01/17/2013 | US20130017205 Inhibition of AXL Signaling in Anti-Metastatic Therapy |
| 01/17/2013 | US20130017198 Manipulation of calcium channels to regulate after-depolarization events in cardiac myocytes |
| 01/17/2013 | US20130017195 Anti-folate receptor alpha antibodies and uses thereof |
| 01/17/2013 | US20130017188 Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
| 01/17/2013 | US20130017179 Lineage-Restricted Neuronal Precursors |
| 01/17/2013 | US20130017178 Preparation created from an in vitro culture of dedifferentiated, non-elicited cells of the argania tree, use thereof for treating skin ageing, inflammation and scarring, and production thereof |
| 01/17/2013 | US20130017175 Activated mesenchymal stem cells for wound healing and impaired tissue regeneration |
| 01/17/2013 | US20130017172 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus |
| 01/17/2013 | US20130017167 Hydrophobic block conjugated therapeutic agents |
| 01/17/2013 | US20130017166 Protein-Poly(2-oxazoline) Conjugates for Enhanced Cellular Delivery and Transport Across Biological Barriers |
| 01/17/2013 | US20130017151 SUBSETS OF ANTIGEN-PRESENTING CELLS (APCs) IN THE HUMAN VAGINA AND THEIR DISTINCT FUNCTIONS |
| 01/17/2013 | CA2841890A1 Hbv polymerase mutants |
| 01/17/2013 | CA2841600A1 Mutant .beta.-glucosidase, enzyme composition for decomposing biomass, and method of producing sugar solution |
| 01/17/2013 | CA2841573A1 Oxidation resistant bioprosthetic tissues and preparation thereof |
| 01/17/2013 | CA2841543A1 Stacked herbicide tolerance event 8264.42.32.1, related transgenic soybean lines, and detection thereof |
| 01/17/2013 | CA2841165A1 Methods for cell reprogramming and genome engineering |
| 01/17/2013 | CA2837809A1 A transgenic system for reversibly immortalizing mammalian quiescent cells |
| 01/16/2013 | EP2546356A1 Methods for Regulation of Stem Cells |
| 01/16/2013 | EP2546345A1 DNA encoding polypeptide involved in biosynthesis of herboxidiene |
| 01/16/2013 | EP2546343A1 Novel lipoxygenases derived from lemna paucicostata |
| 01/16/2013 | EP2546339A1 Mutated alkaline celluase |
| 01/16/2013 | EP2546335A1 Foetal epiphyseal chondrocyte (FEC) parental cell bank |
| 01/16/2013 | EP2546334A1 Method for the in vitro proliferation of cells derived from tissues of endormal origin |
| 01/16/2013 | EP2546333A2 Cardiac stem cells |
| 01/16/2013 | EP2546332A1 Nanotube carrier substrate for primary tissue culture |
| 01/16/2013 | EP2545928A1 Cell preparation containing mesenchymal stem cells, and method for producing same |
| 01/16/2013 | EP2545171A1 Hjurp peptides and vaccines including the same |
| 01/16/2013 | EP2545164A1 Use of markers of undifferentiated pluripotent stem cells |
| 01/16/2013 | EP2545163A1 Method of selecting induced pluripotent stem cell |
| 01/16/2013 | EP2545161A2 Enterobacter sp. 638 and methods of use thereof |
| 01/16/2013 | CN1812800B Muscle derived cells(mdc) for promoting and enhancing nerve repair and regeneration |
| 01/16/2013 | CN1454257B Production of recombinant blood clotting factors in human cell lines |
| 01/16/2013 | CN102884190A HJURP peptides and vaccines including the same |
| 01/16/2013 | CN102884189A Thioesterase and method for producing fatty acid or lipid using same |
| 01/16/2013 | CN102884188A Method for producing induced pluripotent stem cells |
| 01/16/2013 | CN102884177A CD49F promoting proliferation, multipotency and reprogramming of adult stem cells through PI3K/AKT/GSK3 pathway |
| 01/16/2013 | CN102884176A Differentiation of human embryonic stem cells |
| 01/16/2013 | CN102883680A Ayered vascular tubes |
| 01/16/2013 | CN102883595A Jatropha hybrids through female only trait |
| 01/16/2013 | CN102876721A Method for destroying fiber structures of ginkgo fallen leaves quickly and efficiently |
| 01/16/2013 | CN102876717A Method for building immortalized preadipocytes of chicken |
| 01/16/2013 | CN102876715A Retroviral vector for gene therapy for tuberculosis and HIV (Human Immunodeficiency Virus) coinfection and application thereof |
| 01/16/2013 | CN102876707A Preparation method of recombinant poliovirus I-type virus-like particles |
| 01/16/2013 | CN102876706A Method for high-throughput screening recombinant trichoderma reesei for efficiently expressing foreign protein |
| 01/16/2013 | CN102876700A PiggyBac transposon mediated muscle specific expression A-FABP (adipocyte fatty acid binding protein) universal vector construction method |
| 01/16/2013 | CN102876699A Method for establishing transgenic cell line of target genes shRNA (short hairpin ribonucleic acid) interfering propagation of porcine reproductive and respiratory syndrome viruses |
| 01/16/2013 | CN102876693A Xylanase gene xynB as well as expression vector and application of Xylanase gene xynB |
| 01/16/2013 | CN102876688A Method for preparing recombinant polio I virus-like particles |
| 01/16/2013 | CN102876684A Coding gene, eukaryotic host cell and expression method of human interleukin-12 |
| 01/16/2013 | CN102876683A Conotoxin and biological preparation method and application thereof |
| 01/16/2013 | CN102876682A Schistosoma Japonicum polymorphism antigen gene and application thereof as vaccine |
| 01/16/2013 | CN102876680A Soybean-source oleosin gene seed specificity promoter and application thereof |
| 01/16/2013 | CN102876644A Homing endonuclease I-PfoP3I and coding gene and application thereof |
| 01/16/2013 | CN102876641A Soybean purple acid phosphatase GmPAP4 and coding gene and application thereof |
| 01/16/2013 | CN102876640A Cyclodextrin glycosyltransferase mutant and application thereof |
| 01/16/2013 | CN102876637A Anti-GLIPR-2 monoclonal antibody hybridoma cell and anti-GLIPR-2 monoclonal antibody generated from same |
| 01/16/2013 | CN102876636A Monoclonal antibody of hemophilus parasuis resistant OMP5 (outer membrane protein), hybridoma cell strain HPS1E2 and application |
| 01/16/2013 | CN102876635A Haemophilus parasuis outer membrane protein P5 (OMP5) resistant monoclonal antibody, hybridoma cell strain and application |
| 01/16/2013 | CN102876634A PMSG (pregnant mare serum gonadotropin) double-antibody sandwich ELISA (enzyme-linked immunosorbent assay) kit |